Your browser doesn't support javascript.
loading
Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study.
Hughes, Rod; Rapsomaniki, Eleni; Janson, Christer; Keen, Christina; Make, Barry J; Burgel, Pierre-Régis; Tomaszewski, Erin L; Müllerová, Hana; Reddel, Helen K.
Afiliação
  • Hughes R; Research and Early Development, Respiratory and Immunology, Clinical, AstraZeneca, Cambridge, UK. Electronic address: rod.hughes@astrazeneca.com.
  • Rapsomaniki E; Real World Data Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
  • Janson C; Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
  • Keen C; Research and Early Development, Respiratory & Immunology, Clinical, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Make BJ; National Jewish Health and University of Colorado Denver, Denver, CO, USA.
  • Burgel PR; Department of Respiratory Medicine, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Université de Paris, Institut Cochin, Inserm U1016, Paris, France.
  • Tomaszewski EL; Patient Centered Science, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA.
  • Müllerová H; Respiratory & Immunology, Medical and Payer Evidence, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
  • Reddel HK; The Woolcock Institute of Medical Research and the University of Sydney, Sydney, Australia.
Respir Med ; 200: 106921, 2022.
Article em En | MEDLINE | ID: mdl-35820227

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Doença Pulmonar Obstrutiva Crônica Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Doença Pulmonar Obstrutiva Crônica Idioma: En Ano de publicação: 2022 Tipo de documento: Article